267 related articles for article (PubMed ID: 31436182)
1. Ocular surface status in patients with hemifacial spasm under long-lasting treatment with botulinum A toxin: A comparative fellow eye study.
Pellegrini M; Schiavi C; Taroni L; Sebastiani S; Bernabei F; Roda M; Moscardelli F; Giannaccare G
Indian J Ophthalmol; 2019 Sep; 67(9):1405-1409. PubMed ID: 31436182
[TBL] [Abstract][Full Text] [Related]
2. Tear meniscus, corneal topographic and aberrometric changes after botulinum toxin-a injection in patients with blepharospasm and hemifacial spasm.
Bayraktar Bilen N; Bilen Ş; Topçu Yılmaz P; Evren Kemer Ö
Int Ophthalmol; 2022 Aug; 42(8):2625-2632. PubMed ID: 35355169
[TBL] [Abstract][Full Text] [Related]
3. Evaluating the effects of Botulinum Toxin A on tear metrics in patients with hemifacial spasm.
Mali YP; Schultze RL; Wladis EJ
Orbit; 2017 Oct; 36(5):307-310. PubMed ID: 28627956
[TBL] [Abstract][Full Text] [Related]
4. Corneal and Tear Film Changes After Botulinum Toxin-A in Blepharospasm or Hemifacial Spasm.
Gunes A; Demirci S; Koyuncuoglu HR; Tok L; Tok O
Cornea; 2015 Aug; 34(8):906-10. PubMed ID: 26075455
[TBL] [Abstract][Full Text] [Related]
5. Long-term efficacy and safety of botulinum toxin A injections to treat blepharospasm and hemifacial spasm.
Ababneh OH; Cetinkaya A; Kulwin DR
Clin Exp Ophthalmol; 2014 Apr; 42(3):254-61. PubMed ID: 23844601
[TBL] [Abstract][Full Text] [Related]
6. [Botulinum toxin type A influence on the lacrimal function of patients with facial dystonia].
Oliveira FC; Oliveira GC; Cariello AJ; Felberg S; Osaki MH
Arq Bras Oftalmol; 2010; 73(5):405-8. PubMed ID: 21225122
[TBL] [Abstract][Full Text] [Related]
7. Use of Alleviating Maneuvers for Periocular Facial Dystonias.
Kilduff CL; Casswell EJ; Salam T; Hersh D; Ortiz-Perez S; Ezra D
JAMA Ophthalmol; 2016 Nov; 134(11):1247-1252. PubMed ID: 27606483
[TBL] [Abstract][Full Text] [Related]
8. Effects of botulinum toxin type A on the treatment of dry eye disease and tear cytokines.
Choi MG; Yeo JH; Kang JW; Chun YS; Lee JK; Kim JC
Graefes Arch Clin Exp Ophthalmol; 2019 Feb; 257(2):331-338. PubMed ID: 30552510
[TBL] [Abstract][Full Text] [Related]
9. [Lacrimal film evaluation of patients with facial dystonia during botulinum toxin type A treatment].
Costa PG; Cardoso IP; Saraiva FP; Raiza AC; Tanaka LK; Matayoshi S
Arq Bras Oftalmol; 2006; 69(3):319-22. PubMed ID: 16936952
[TBL] [Abstract][Full Text] [Related]
10. [Safety and efficacy of botulinum toxin in hemifacial spasm].
Mazlout H; Kamoun Gargouri H; Triki W; Kéfi S; Brour J; El Afrit MA; Chéour M; Kraiem A
J Fr Ophtalmol; 2013 Mar; 36(3):242-6. PubMed ID: 23270989
[TBL] [Abstract][Full Text] [Related]
11. Dry Eye Disease in Hemifacial Spasm Patients Treated with Botulinum Toxin Type A.
Jariyakosol S; Uthaithammarat L; Chatwichaikul N; Kasetsuwan N; Chongpison Y
Clin Ophthalmol; 2021; 15():1775-1782. PubMed ID: 33953536
[TBL] [Abstract][Full Text] [Related]
12. Tear film osmolarity in ocular mucous membrane pemphigoid.
Miserocchi E; Iuliano L; Berchicci L; Bandello F; Modorati G
Cornea; 2014 Jul; 33(7):668-72. PubMed ID: 24858022
[TBL] [Abstract][Full Text] [Related]
13. Botulinum toxin type a injection for lateral canthal rhytids : effect on tear film stability and tear production.
Ho MC; Hsu WC; Hsieh YT
JAMA Ophthalmol; 2014 Mar; 132(3):332-7. PubMed ID: 24385079
[TBL] [Abstract][Full Text] [Related]
14. Increase lipid tear thickness after botulinum neurotoxin A injection in patients with blepharospasm and hemifacial spasm.
Ho RW; Fang PC; Chao TL; Chien CC; Kuo MT
Sci Rep; 2018 May; 8(1):8367. PubMed ID: 29849166
[TBL] [Abstract][Full Text] [Related]
15. Pain relief in patients receiving periocular botulinum toxin A.
Harrison AR; Erickson JP; Anderson JS; Lee MS
Ophthalmic Plast Reconstr Surg; 2008; 24(2):113-6. PubMed ID: 18356715
[TBL] [Abstract][Full Text] [Related]
16. Effect of botulinum toxin type a on tear production after treatment of lateral canthal rhytids.
Arat YO; Yen MT
Ophthalmic Plast Reconstr Surg; 2007; 23(1):22-4. PubMed ID: 17237684
[TBL] [Abstract][Full Text] [Related]
17. Local injection of botulinum toxin type A for hemifacial spasm.
Oyama H; Ikeda A; Inoue S; Nakashima Y; Shibuya M
Neurol Med Chir (Tokyo); 2002 Jun; 42(6):245-8; discussion 248-9. PubMed ID: 12116529
[TBL] [Abstract][Full Text] [Related]
18. Ocular surface alterations in blepharospasm patients treated with botulinum toxin A injection.
Kocabeyoglu S; Sekeroglu HT; Mocan MC; Muz E; Irkec M; Sanac AS
Eur J Ophthalmol; 2014; 24(6):830-4. PubMed ID: 24803156
[TBL] [Abstract][Full Text] [Related]
19. Differences in Corneal Parameters Between Affected and Normal Contralateral Eyes in Patients With Hemifacial Spasm Treated With Botulinum Toxin-A: Outcomes During One Complete Treatment Cycle.
Osaki T; Osaki MH; Osaki TH; Hirai FE; Campos M
Cornea; 2016 Feb; 35(2):220-5. PubMed ID: 26619386
[TBL] [Abstract][Full Text] [Related]
20. Botulinum toxin A treatment in patients suffering from blepharospasm and dry eye.
Horwath-Winter J; Bergloeff J; Floegel I; Haller-Schober EM; Schmut O
Br J Ophthalmol; 2003 Jan; 87(1):54-6. PubMed ID: 12488263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]